comparemela.com
Home
Live Updates
Celcuity Inc.: Celcuity to Present Additional Data for Gedatolisib at the 2022 San Antonio Breast Cancer Symposium : comparemela.com
Celcuity Inc.: Celcuity to Present Additional Data for Gedatolisib at the 2022 San Antonio Breast Cancer Symposium
MINNEAPOLIS, MN / ACCESSWIRE / November 22, 2022 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company focused on development of targeted therapies for cancer treatment, today announced
Related Keywords
Vicky Hahne
,
Kostenloser Wertpapierhandel
,
Robert Wesolowski
,
Robert Uhl
,
Brian Sullivan
,
Linkedin
,
Exchange Commission On
,
Twitter
,
Celcuity Inc
,
Celcuity Inc View
,
Nasdaq
,
Spotlight Poster
,
Antonio Breast Cancer Symposium
,
Spotlight Poster Discussion Session
,
Spotlight Poster Discussion
,
Risk Factors
,
Quarterly Report
,
Exchange Commission
,
Celcuity
,
Present
,
Dditional
,
Data
,
Gedatolisib
,
022
,
Antonio
,
Breast
,
Dancer
,
Symposium
,
comparemela.com © 2020. All Rights Reserved.